2016-2020 CMV Testing Market: Supplier Shares, Sales Forecasts, Innovative Technologies, Competitive Strategies, Emerging Opportunities – US, Europe (France, Germany, Italy, Spain, UK), Japan – Diagnostics, Healthcare, Healthcare Services, Infectious Disease Testing Industries

The 2016-2020 CMV Testing Market: Supplier Shares, Sales Forecasts, Innovative Technologies, Competitive Strategies, Emerging Opportunities – US, Europe (France, Germany, Italy, Spain, UK), Japan Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, Infectious Disease Testing Markets.

The report presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the CMV definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:

– Hospitals
– Commercial/Private Labs
– Blood Banks
– Physician Offices
– Public Health Labs

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of CMV tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 231 pages and 15 tables

Read more and order at 2016-2020 CMV Testing Market: Supplier Shares, Sales Forecasts, Innovative Technologies, Competitive Strategies, Emerging Opportunities – US, Europe (France, Germany, Italy, Spain, UK), Japan

Endocrine Function Market 2021: US, Europe, Japan-Supplier Shares and Strategies, Volume and Sales Segment Forecasts – Diagnostics, Healthcare, Healthcare Services Industries

The Endocrine Function Market 2021: US, Europe, Japan-Supplier Shares and Strategies, Volume and Sales Segment Forecasts Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services Markets.

This new 327-page report contains 75 tables and provides analysis of the global endocrine function diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays:

Cortisol
Estradiol
FSH
HCG
Gastrin
LH
Progesterone
PTH/IO PTH
Prolactin
T3
T3 Uptake
Free T3
T4
Free T4
TBG
Testosterone
Thyroglobulin Ab
TPO Ab
TSH

During the next decade, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

This unique worldwide market and technology assessment is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; provides test volume and sales forecasts; compares features of leading analyzers; and profiles key competitors.

Contains 327 pages and 75 tables

Read more and order at Endocrine Function Market 2021: US, Europe, Japan-Supplier Shares and Strategies, Volume and Sales Segment Forecasts

2016-2020 IgM Test Volume and Sales Forecasts by Country and Market Segment – USA, EU5, Japan – Hospitals, Commercial Labs, POC Locations – Diagnostics, Healthcare, Healthcare Services, Point-of-Care Diagnostics Industries

The 2016-2020 IgM Test Volume and Sales Forecasts by Country and Market Segment – USA, EU5, Japan – Hospitals, Commercial Labs, POC Locations Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, Point-of-Care Diagnostics Markets.

This new report provides analysis of IgM testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Market Segmentation

Centralized Testing

– Hospitals
– Commercial/Private Laboratories

POC/Decentralized Testing

– Physician Offices/Group Practices
– Ambulatory Care Centers

List of Tables

France: IgM Test Volume and Diagnostics Sales Forecasts by Market Segment

Germany: IgM Test Volume and Diagnostics Sales Forecasts by Market Segment

Italy: IgM Test Volume and Diagnostics Sales Forecasts by Market Segment

Japan: IgM Test Volume and Diagnostics Sales Forecasts by Market Segment

Spain: IgM Test Volume and Diagnostics Sales Forecasts by Market Segment

UK: IgM Test Volume and Diagnostics Sales Forecasts by Market Segment

USA: IgM Test Volume and Diagnostics Sales Forecasts by Market Segment

Read more and order at 2016-2020 IgM Test Volume and Sales Forecasts by Country and Market Segment – USA, EU5, Japan – Hospitals, Commercial Labs, POC Locations

CEA Test Volume and Sales Forecasts: US, Europe, Japan – Hospitals, Commercial Labs, POC Locations – Diagnostics, Healthcare, Healthcare Services, Point-of-Care Diagnostics Industries

The CEA Test Volume and Sales Forecasts: US, Europe, Japan – Hospitals, Commercial Labs, POC Locations Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, Point-of-Care Diagnostics Markets.

This new report a provides analysis of CEA testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Market Segmentation

Centralized Testing

– Hospitals
– Commercial/Private Laboratories

POC/Decentralized Testing

– Physician Offices/Group Practices
– Cancer Clinics

List of Tables

France: CEA Test Volume and Diagnostics Sales Forecasts by Market Segment

Germany: CEA Test Volume and Diagnostics Sales Forecasts by Market Segment

Italy: CEA Test Volume and Diagnostics Sales Forecasts by Market Segment

Japan: CEA Test Volume and Diagnostics Sales Forecasts by Market Segment

Spain: CEA Test Volume and Diagnostics Sales Forecasts by Market Segment

UK: CEA Test Volume and Diagnostics Sales Forecasts by Market Segment

USA: CEA Test Volume and Diagnostics Sales Forecasts by Market Segment

Read more and order at CEA Test Volume and Sales Forecasts: US, Europe, Japan – Hospitals, Commercial Labs, POC Locations

Gap Junctions: Molecular Basis of Cell Communication in Health and Disease, Vol 49. Current Topics in Membranes – Diagnostics, Healthcare, Healthcare Services Industries

The Gap Junctions: Molecular Basis of Cell Communication in Health and Disease, Vol 49. Current Topics in Membranes Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services Markets.

Since the first gap junction protein (connexin) was cloned over a decade ago, more than a dozen connexin genes have been cloned. Consequently, a wealth of information on the molecular basis of gap junctional communication has been accumulated. This book pays tribute to this exciting era in the history of cell communication research by documenting the great strides made in this field as a result of the merging of biophysics and molecular biology, two of the most powerful approaches to studying the molecular basis of membrane channel behavior. Twenty-eight comprehensive chapters, authored by internationally recognized leaders in the field, discuss the biophysical, physiological, and molecular characteristics of cell-to-cell communication via gap junctions. Key aspects of molecular structure, formation, gating, conductance, and permeability of vertebrate and invertebrate gap junction channels are highlighted. In addition, a number of chapters focus on recent discoveries that implicate connexin mutations and alterations of gap junctional communication in the pathogenesis of several diseases, including the X-linked Charcot-Marie-Tooth demyelinating disease, some forms of inherited sensorineural deafness, malignant transformation, cardiac malformations and arrhythmia, eye lens cataract, and Chagas disease.

Read more and order at Gap Junctions: Molecular Basis of Cell Communication in Health and Disease, Vol 49. Current Topics in Membranes

Liquid Biopsy Markets by Lung, Breast, Colorectal, Prostate and Other. 2017-2020 Including Screening Market Potential Size with Executive and Consultant Guides – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics Industries

The Liquid Biopsy Markets by Lung, Breast, Colorectal, Prostate and Other. 2017-2020 Including Screening Market Potential Size with Executive and Consultant Guides Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics Markets.

The Diagnostic, Monitoring and Screening Test opportunities are explored.

A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA.  The technology creates new markets for cancer screening tests.

GRAIL, a new company with impressive backing, has announced a single blood test to detect all cancers. The technology is moving faster than the market. New technology that definitively identifies disease conditions from blood samples is poised to replace expensive invasive surgical biopsy procedures. The market is still in its infancy but has outstanding growth potential. The impact on the health care industry is enormous. The report forecasts the market size out to 2020. In addition, the report looks at potential market sizes by country, by cancer and by the three different opportunities: detection, management and screening.

Use independent research that makes you the expert. Get our research team working for you by ordering this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. Get an extra player on your team as unlimited assistance and breakout data is included with your purchase.

Circulating Tumor Cells? Cell Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate and Other Cancers. 

What is the size of the huge screening opportunity? They are all listed in Chapter 10.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.  

Read more and order at Liquid Biopsy Markets by Lung, Breast, Colorectal, Prostate and Other. 2017-2020 Including Screening Market Potential Size with Executive and Consultant Guides

2016-2020 Emerging Opportunities in the UK Respiratory Diseases Diagnostic Testing Market – Diagnostics, Healthcare, Healthcare Services Industries

The 2016-2020 Emerging Opportunities in the UK Respiratory Diseases Diagnostic Testing Market Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services Markets.

About This Report

This new 281-page report from the publisher presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs.

In addition to market share and sales forecasts, the report:

-  Examines market applications of Molecular Diagnostics,  
   Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

-  Reviews features and operating characteristics of major analyzers used 
   for microbiology testing;

-  Profiles key suppliers and potential market entrants developing innovative
   technologies and products; and

-  Analyzes emerging opportunities, alternative market penetration strategies, 
   market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as ’s proprietary data files was conducted.

Contains 281  pages and 21  tables

Read more and order at 2016-2020 Emerging Opportunities in the UK Respiratory Diseases Diagnostic Testing Market

France Molecular Diagnostics Market 2017: Sales and Market Shares of Major Suppliers – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The France Molecular Diagnostics Market 2017: Sales and Market Shares of Major Suppliers Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This unique report provides France sales and market share estimates for major suppliers of molecular diagnostic products.

The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Competitive Assessments

– Abbott

  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Biotest
  • CellMark Forensics/LabCorp
  • Cepheid
  • Decode Genetics
  • Diadexus
  • Eiken
  • Elitech Group
  • Enzo
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Monogram Biosciences
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan Group
  • Thermo Fisher

List of Tables

France Molecular Diagnostics Market By Major Supplier
France HIV/Hepatitis NAT Market Reagent Sales By Major Supplier

Contains 121 pages and 2 tables

Read more and order at France Molecular Diagnostics Market 2017: Sales and Market Shares of Major Suppliers

Japan Respiratory Diseases Diagnostic Testing Market, 2021 – Diagnostics, Healthcare, Healthcare Services Industries

The Japan Respiratory Diseases Diagnostic Testing Market, 2021 Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services Markets.

About This Report

This new 282-page report presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.

In addition to market share and sales forecasts, the report:

– Examines market applications of Molecular Diagnostics,
Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

– Reviews features and operating characteristics of major analyzers used
for microbiology testing;

– Profiles key suppliers and potential market entrants developing innovative
technologies and products; and

– Analyzes emerging opportunities, alternative market penetration strategies,
market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as proprietary data files was conducted.

Contains 282 pages and 22 tables

Read more and order at Japan Respiratory Diseases Diagnostic Testing Market, 2021

HIV/AIDS Diagnostic Testing Market, 2021 – Diagnostics, Healthcare, Healthcare Services, Infectious Disease Testing Industries

The HIV/AIDS Diagnostic Testing Market, 2021 Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, Infectious Disease Testing Markets.

The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. The report provides the 5-year test volume and sales forecasts by country for HIV-1/2/Combo, HIV Ag, HTLV-I/II, Western Blot and other confirmatory tests performed in the following markets:

– Hospitals – Public Health Labs – Commercial/Private Labs
– Blood Banks – Physician Offices – Ambulatory Care Centers

For each country, in addition to the test volume and sales projections, the report presents the sales and market share estimates for major suppliers of AIDS tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies profiles leading suppliers and recent market entrants developing innovative technologies and products and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 292 pages and 36 tables

Read more and order at HIV/AIDS Diagnostic Testing Market, 2021